Učitavanje...
Optimal maintenance and consolidation therapy for multiple myeloma in actual clinical practice
Multiple myeloma is an incurable malignant plasma cell-originating cancer. Although its treatment outcomes have improved with the use of glucocorticoids, alkylating drugs, and novel agents, including proteasome inhibitors (bortezomib and carfilzomib) and immunomodulatory drugs (thalidomide, lenalido...
Spremljeno u:
| Izdano u: | Korean J Intern Med |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
The Korean Association of Internal Medicine
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5016292/ https://ncbi.nlm.nih.gov/pubmed/27604793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2016.110 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|